Paper: GS – III, Subject: Science and Technology, Topic: Medical science and Health, Issue: GLP-1 Drug.
Context:
The expiry of semaglutide patents in India has enabled the entry of cheaper generic versions of GLP-1 receptor agonists, widely used for Type-2 diabetes and obesity management.
- With India facing a growing burden of obesity and diabetes, these drugs present both a public health opportunity and a regulatory challenge.
Key Takeaways:
Nature and Mechanism:
- GLP-1 receptor agonists mimic gut hormones that regulate appetite, insulin secretion and blood glucose levels.
- They aid weight loss, improve glycaemic control and reduce cardiovascular risks.
- Common formulations include semaglutide-based drugs administered via injections or oral forms. Public Health Significance
- India has one of the largest populations of diabetics and a rapidly rising obesity burden.
- Wider access to these drugs can improve metabolic health outcomes, especially for middle- and lower-income groups.
- They complement lifestyle interventions such as diet and exercise in chronic disease management.
- The World Health Organization has recently released global guidelines on the use of widely used GLP-1 drugs for weight loss.
Regulatory Framework in India:
- GLP-1 drugs are classified as Schedule H medicines, requiring a valid prescription.
- The Central Drugs Standard Control Organisation oversees approval, safety and quality standards.
- Pharmacovigilance mechanisms exist but require strengthening for large-scale deployment.
Policy Imperatives:
- Strengthen prescription protocols and enforce restrictions on non-prescribed sale.
- Develop India-specific clinical guidelines and eligibility criteria.
- Enhance pharmacovigilance systems for long-term monitoring of outcomes and side effects.
- Regulate advertising to prevent misleading claims and misuse.
- Promote integration with lifestyle-based interventions for holistic care.
Conclusion:
GLP-1 drugs represent a significant advancement in managing diabetes and obesity in India. However, their benefits can be fully realised only through a balanced approach that combines wider access with robust regulatory safeguards, ensuring safe, equitable and rational use.
Source: (The Hindu)
La Excellence IAS Academy, the best IAS coaching in Hyderabad, known for delivering quality content and conceptual clarity for UPSC 2026 preparation.
FOLLOW US ON:
â—‰ YouTube : https://www.youtube.com/@CivilsPrepTeam
â—‰ Facebook: https://www.facebook.com/LaExcellenceIAS
â—‰ Instagram: https://www.instagram.com/laexcellenceiasacademy/
GET IN TOUCH:
Contact us at info@laex.in, https://laex.in/contact-us/
or Call us @ +91 9052 29 2929, +91 9052 99 2929, +91 9154 24 2140
OUR BRANCHES:
Head Office: H No: 1-10-225A, Beside AEVA Fertility Center, Ashok Nagar Extension, VV Giri Nagar, Ashok Nagar, Hyderabad, 500020
Madhapur: Flat no: 301, survey no 58-60, Guttala begumpet Madhapur metro pillar: 1524, Rangareddy Hyderabad, Telangana 500081
Bangalore: Plot No: 99, 2nd floor, 80 Feet Road, Beside Poorvika Mobiles, Chandra Layout, Attiguppe, Near Vijaya Nagara, Bengaluru, 560040